Lantheus Holdings, Inc. Logo

Lantheus Holdings, Inc.

Develops radiopharmaceutical diagnostics and therapies to help clinicians fight disease.

LNTH | US

Overview

Corporate Details

ISIN(s):
US5165441032
LEI:
Country:
United States of America
Address:
331 TREBLE COVE ROAD, 1862 NORTH BILLERICA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Lantheus Holdings, Inc. is a leading radiopharmaceutical-focused company specializing in the development, manufacturing, and commercialization of innovative diagnostic and therapeutic products. For over 65 years, the company has pioneered next-generation solutions that assist clinicians in the diagnosis and treatment of diseases. Its portfolio includes precision diagnostics, radiotherapeutics, and artificial intelligence solutions designed to help healthcare professionals 'Find, Fight, and Follow' disease, aiming to improve patient outcomes through advanced medical imaging and targeted therapies.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Lantheus Holdings, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Lantheus Holdings, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Lantheus Holdings, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Sensei Biotherapeutics, Inc. Logo
Developing tumor-activated biologics to stimulate a targeted immune response against cancer.
United States of America
SNSE
Senti Biosciences, Inc. Logo
Developing smart cell and gene therapies with Gene Circuits to precisely target cancer.
United States of America
SNTI
SEOUL PHARMA CO.,LTD Logo
Develops pharmaceuticals with innovative Orally Disintegrating Film (ODF) tech for global markets.
South Korea
018680
Septerna, Inc. Logo
Advancing novel small molecule GPCR medicines for endocrine, immune, and metabolic diseases.
United States of America
SEPN
SERA PROGNOSTICS, INC. Logo
Develops predictive blood tests to assess preterm birth risk and improve pregnancy outcomes.
United States of America
SERA
Seres Therapeutics, Inc. Logo
Developing live biotherapeutics from the microbiome to treat infections and immune diseases.
United States of America
MCRB
Serina Therapeutics, Inc. Logo
Developing safer, more effective drugs for neurology and cancer using polymer technology.
United States of America
SER
SEYİTLER KİMYA SANAYİ A.Ş. Logo
Manufacturer of medical tapes, wound dressings, and first aid plasters for the healthcare industry.
Türkiye
SEYKM
Shaperon Inc. Logo
Develops inflammasome inhibitors & nanobodies for inflammatory diseases and cancer.
South Korea
378800
Shattuck Labs, Inc. Logo
Clinical-stage biotech developing novel biologic medicines for inflammatory & autoimmune diseases.
United States of America
STTK

Talk to a Data Expert

Have a question? We'll get back to you promptly.